JennyCo (JCO) stands at the forefront of healthcare innovation, leading the way in pioneering a revolutionary Web 3.0 and HIPAA-compliant health data marketplace. The inherent value of a single individuals healthcare data, estimated between $2000 and $8000 annually (E&Y 2019) for corporate data mining, serves as the catalyst for our cutting-edge integration of AI (LLM) and Blockchain technologies. JCO reimagines healthcare data as digital currency.
Please see useful links below:
By effectively tokenizing real-world healthcare assets (EHR, lab results, IoT, etc.) we harness the profound impact of genetics verses lifestyle to also deliver personalized health insights and compensation to the user on a mobile app. At JCO, we empower individuals to efficiently organize, securely store, monetize, and maintain control over their healthcare data. We enable users to be a broker for their own health information.
Our AI and data mining platform also delivers curated health insights for large corporations, enabling informed healthcare decisions, and one-to-one user engagement with our data mining services. In summary, JCO offers a reliable, secure platform for health data storage, portability, renumeration and exchange; helping users to take control of their health and financial well-being:
The business model and revenue streams of JCO are diverse and encompass a consumer app and AI subscription services, lab test sales, ongoing NFTs and consumer product sales, health data storage and portability service, telemedicine, and more. For corporate customers, opportunities include data mining and leasing, product placement, and licensing of the platform and AI-machine system (SaaS).
JCO has previously secured $1.2 million in funding from retail and private capital groups, and also generated $250K in revenue in just one month (Nov 2023) through an inaugural DNA test/NFT sale, which was completely sold out. Company Total Market Cap is $15 Million. The initial public $JCO Utility Token was also launched in late 2023, and currently has a market cap of $3 Million.
Backed by an experienced founding team and Board, comprising medical doctors, scientists, engineers in blockchain, crypto and tokenomics, AI and machine learning experts, consumer healthcare and BD specialists, marketing professionals; and numerous established corporate alliances, JCO is well-equipped to capture a substantial portion of the growing personal healthcare data industry.
Initial Team:
Michael Nova MD (JennyCo Co-Founder, Board Member, and CEO)
● Background in Computer Science, Medicine, and Genetics. Founder of numerous companies and the inventor of many genetic testing assays and mobile AI applications,
● Founder/CEO of drug-discovery company Discovery Partners Inc. (Nasdaq: DPII), $150M IPO.
● 2006 World Economic Forum (WEF) Technology Pioneer Award Winner; and the Physician-Of-Record for the first person to have their entire genome sequenced by Illumina (2009).
● Dr Nova has 32 issued patents in the subject areas of Artificial Intelligence, Genetics, Wireless Peer-to-Peer Decentralized Data, and other technologies.
Jenny Diggles MBA (JennyCo Co-Founder, Board Member)
● Strategic advisor for companies and VIPs with expertise in tech, international business development, medicine, politics, blockchain, cannabis, and crypto currencies.
● Entrepreneur with track record of building successful businesses on the edge of emerging industries
● Requested and selected by Apple to participate in their first TV show to showcase a mobile App she developed
● Saw Cura Cannabis through an acquisition by CuraLeaf (OTCMKTS: CURLF) and developed strategic relationships and introductions for CuraLeaf.
Linden Leadbetter, MD MBA (Head of Token Economics)
● Background in derivatives, crypto and algo trading. Previous head of Europe for Bear Stearns Bank
● Medical doctor with a fellowship in genetic medicine
● Expert in crypto tokenomics, DAO, and innovative use cases
● Dr. Leadbetter received his M.D. from Nottingham University. A BSc (hons) in Physics from Durham University. An MBA from Trinity College Dublin
Steve Carter, Ph.D (Chief Scientific Officer, Healthcare)
● CEO of Zulia Biotech, developing novel therapeutics for the treatment of neurodegenerative diseases
● Managing Director for Intrepid Life Sciences, development of new biotech/data companies from university-based technologies.
● Previously he has served in various leadership positions with Vicapsys Life Sciences, Valeant Pharmaceuticals, Biochemics, Harvard Medical School, Glaxo Wellcome and the National Cancer Institute-Frederick Cancer Research Facility.
● Dr. Carter received his Ph.D. from the department of Biochemistry and Biophysics at Iowa State University, and completed a ,fellowship in molecular virology and served on the research faculty at the Yale University.
Manish Vishnoi, MS CS (Chief Technology Officer)
● Extensive knowledge of healthcare software systems and platforms, including data, AI, and compliance
● Co-authored publications highlighting use cases of HIPAA blockchain technologies in healthcare applications
● Over 5 years of software development leadership for global enterprises (Oracle, United Healthcare, Cisco)
● Master of Science in Computer Science from leading blockchain group at Arizona State University
Board of Directors (7):
● Michael Nova (Founder)
● Jenny Diggles (Founder)
● Rick Varnell
● Travis Bond MD
● General Steve Lanza
● Steve Sansom
Steve is the founder and chairman of The Green Square Capital Advisors, Green Square Family Office, Green Square Strategy and Green Square Wealth Advisors in Memphis, TN. He was previously a founder and member of the board of directors of Center Coast Capital Advisors, one of the largest independent investors in U.S. mid-stream energy infrastructure assets. Center Coast Capital owned and operated a publicly traded energy infrastructure company traded on the New York Stock Exchange(CEN). Steve currently serves on the Executive Advisory Board of Brown Brothers Harriman Capital Partners the middle markets private equity investment group at Brown Brothers Harriman & Co. in New York, NY. Steve graduated from Harvard Business School.
Bill was the CEO of Nortel Telecommunications and the CEO/Chairman of Teledesic LLC, a Bill Gates/Craig McCaw company bringing worldwide broadband through an extensive satellite network. Bill was also Chairman and Senior Partner of AEA Investors Asia. He has been a board member of 23 public companies. Currently, Bill is also on the Board of Directors at Wipro Technologies.